Inventor · disambiguated record
Nicole Schmidt
Also filed as: SCHMIDT NICOLE
12 granted patents·10 pending applications·56 citations·filing 2014–2023
88Inventor score
Top patents by PatentIndex Score
22 records- 0195US10308634B2Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugsBayer Pharma AG·Filed 2015·Granted Jun 4, 2019·17 cites·27 claims
- 0292US10793545B2Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugsBayer Pharma AG·Filed 2019·Granted Oct 6, 2020·7 cites·27 claims
- 0390US12006303B2Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said substituted indazoles, and use of said substituted indazoles to produce drugsBayer Pharma AG·Filed 2022·Granted Jun 11, 2024·1 cites·24 claims
- 0490US12006304B2Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said substituted indazoles, and use of said substituted indazoles to produce drugsBayer Pharma AG·Filed 2022·Granted Jun 11, 2024·1 cites·9 claims
- 0590US9951086B2Indazolecarboxamides, processes for their preparation, pharmaceutical preparations comprising them and their use for producing medicamentsBayer Pharma AG·Filed 2014·Granted Apr 24, 2018·21 cites·19 claims
- 0685US10435396B22-substituted indazoles, methods for producing same, pharmaceutical preparations that contain same, and use of same to produce drugsBayer Pharma AG·Filed 2017·Granted Oct 8, 2019·7 cites·8 claims
- 0772US11905270B2Carboxylic acid aromatic amides as antagonists of bradykinin B1 receptorBayer Pharma AG·Filed 2017·Granted Feb 20, 2024·1 cites·3 claims
- 0870US11992481B2Use of 2-substituted indazoles for the treatment and prophylaxis of autoimmune diseasesBayer Pharma AG·Filed 2022·Granted May 28, 2024·0 cites·12 claims
- 0970US2021053941A1Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugsBayer Pharma AG·Filed 2020·Application pending·0 cites
- 1069US2022241261A1Combinations of inhibitors of irak4 with inhibitors of btkBayer Pharma AG·Filed 2021·Application pending·0 cites
- 1168US12239630B2Carboxylic acid aromatic amides as antagonists of bradykinin B1 receptorBayer Pharma AG·Filed 2023·Granted Mar 4, 2025·0 cites·3 claims
- 1267US12459916B2Substituted indazoles useful for treatment and prevention of allergic and/or inflammatory diseases in animalsBayer Pharma AG·Filed 2022·Granted Nov 4, 2025·0 cites·22 claims
- 1367US2019388410A1Combinations of inhibitors of irak4 with inhibitors of btkBayer Pharma AG·Filed 2019·Application pending·0 cites
- 1466US12023319B2Carboxylic acid aromatic amidesBayer Pharma AG·Filed 2021·Granted Jul 2, 2024·0 cites·5 claims
- 1566US10487092B2Pyrazolopyridinamines as MKNK1 and MKNK2 inhibitorsBayer Pharma AG·Filed 2015·Granted Nov 26, 2019·1 cites·22 claims
- 1657US2018289685A1Combinations of inhibitors of irak4 with inhibitors of btkBayer Pharma AG·Filed 2016·Application pending·0 cites
- 1755US2021085664A1Use of 2-substituted indazoles for the treatment and prophylaxis of autoimmune diseasesBayer Pharma AG·Filed 2020·Application pending·0 cites
- 1854US2022339297A1Human gene therapy methods for hemophilia aBAYER HEALTHCARE LLC·Filed 2022·Application pending·0 cites
- 1951US2024417407A1Furoindazole derivatives as gpr84 antagonistsBAYER AG·Filed 2022·Application pending·0 cites
- 2046US2019125736A1Use of 2-substituted indazoles for the treatment and prophylaxis of autoimmune diseasesBayer Pharma AG·Filed 2017·Application pending·0 cites
- 2146US2020216413A1Substituted indazoles useful for treatment and prevention of allergic and/or inflammatory diseases in animalsBAYER ANIMAL HEALTH GMBH·Filed 2017·Application pending·0 cites
- 2238US2021317092A1Tetrazole containing compoundsBayer Pharma AG·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nicole Schmidt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →